3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
Cyclophosphamide
8
Whole-Body Irradiation
6
fludarabine
5
fludarabine phosphate
4
Tacrolimus
4
Mycophenolic Acid
4
Melphalan
4
Busulfan
3
luspatercept
2
Vorinostat
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Biopsy
2
Azacitidine
2
AP 1903 reagent
2
venetoclax
1
ribociclib
1
palbociclib
1
olaparib
1
ibrutinib
1
hetrombopag
1
edoxaban
1
decitabine and cedazuridine drug combination
1
apixaban
1
acalabrutinib
1
abemaciclib
1
Valganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Dabigatran
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled